about
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosisOptical coherence tomography: a window into the mechanisms of multiple sclerosisOptical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderRetinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypesIn vivo evaluation of retinal neurodegeneration in patients with multiple sclerosisOptical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.Inner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritis.Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.Analysis of macular OCT images using deformable registration.Retinal architecture and mfERG: Optic nerve head component response characteristics in MSDiffusion tensor imaging of the optic tracts in multiple sclerosis: association with retinal thinning and visual disabilityRetinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomographyRetinal and optic nerve head pathology in Susac's syndrome.Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosisIsolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.Focal macular photopic negative response in patients with optic neuritisOptical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritisAmiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.Investigating Tissue Optical Properties and Texture Descriptors of the Retina in Patients with Multiple SclerosisMicrocystic macular oedema in multiple sclerosis is associated with disease severityMeasurement of the retinal nerve fibre layer with scanning laser polarimetry in patients with previous demyelinating optic neuritisOptical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study.Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective studyLong non-coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling.Detection of retinal blood vessel changes in multiple sclerosis with optical coherence tomography.Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosisMultiple-object geometric deformable model for segmentation of macular OCTDiagnostic capability of retinal thickness measures in diabetic peripheral neuropathy.Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective.Optical Coherence Tomography and Subclinical Optical Neuritis in Longitudinally Extensive Transverse Myelitis.A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis
P2860
Q24650437-D0408F53-7296-4B81-A6C9-B0BB2191D7A7Q24655514-7E5F7013-FC28-4E6C-95DD-F0322DA8E075Q28076588-BE1BBDED-84B8-40B8-8986-E16C6A47D97AQ28729713-5706A19B-A833-4E8C-90EB-55EA4639555EQ28732415-F5BE1CD7-B385-463A-8453-E6C35618364BQ30499517-7A246EA9-BF1C-4004-90C9-AF623B43A816Q31140679-4F16A1FC-3145-4C34-846B-BD41487A7478Q33648360-0BBC88E1-85AE-4EA9-B688-3DFADAC6E64DQ33882723-C463432F-0E12-4942-B129-A2D933CB429EQ33915815-663D5AF8-871B-4821-88DD-453399EE8154Q33927190-89290E22-4F33-4659-A4B5-D5242F9BFA99Q33942965-3CC5C297-26C0-492B-A632-6D5FF794AA00Q34161093-62C7CBE8-EE5F-4257-BDD0-DC9D4F5B5E4AQ34472254-14B9B3FB-D0C0-474F-AD1D-8C48ECE57EEBQ34785270-048A6F70-85DB-4EEA-81E3-90874F03C820Q34992546-D849E6FF-8751-461B-BFC3-650524390950Q35022730-B68B2BD5-F5E1-4C47-8664-BE3D93B86471Q35209875-F5B033EC-3102-4381-B783-46731BA42D59Q35762462-945E04E9-EC06-44D2-80CD-1A78620AD122Q35836853-B504BFA4-6495-4482-B3F7-261AC35E9D07Q35855972-DFF46772-714D-4A23-940C-DAB307376FEBQ35986688-B9610CA0-DE86-494F-A25F-67D75EAF6618Q36318083-B4182159-4827-4172-9D83-F14F044C2C29Q36435667-E2CCF2B5-6218-422A-A0AB-5EB53E64D124Q36496806-5875CFF5-F22E-4B56-8DA5-F2021882F260Q36759495-45E48599-06D5-4CB3-894D-4CF525AE4ADEQ37032357-8FD3A9D7-B07C-4F76-AB25-998A587B21ECQ37253751-09B7595A-847B-457B-8E92-F9BAAF22ACF8Q37316388-8E18AB0F-64E6-4207-81C1-5C9ED078E151Q38741574-66677A38-FFF2-41CD-99A6-985B0EDC2CAEQ41231938-3480EC11-BF8C-4770-A9E8-36C6D1233855Q42925466-167F116C-BFBC-47D9-9B0C-E4DC358FFEB5Q47103289-F3035683-8C52-4A9B-8224-B28E1D35B1D4Q58741638-3C8553B9-D94F-454C-960F-D99734F6EE8F
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Retinal pathologic changes in multiple sclerosis.
@ast
Retinal pathologic changes in multiple sclerosis.
@en
Retinal pathologic changes in multiple sclerosis.
@nl
type
label
Retinal pathologic changes in multiple sclerosis.
@ast
Retinal pathologic changes in multiple sclerosis.
@en
Retinal pathologic changes in multiple sclerosis.
@nl
prefLabel
Retinal pathologic changes in multiple sclerosis.
@ast
Retinal pathologic changes in multiple sclerosis.
@en
Retinal pathologic changes in multiple sclerosis.
@nl
P2093
P1433
P1476
Retinal pathologic changes in multiple sclerosis.
@en
P2093
P304
P577
1994-01-01T00:00:00Z